Drupal.behaviors.print = function(context) {window.print();window.close();}>
Rosetta Genomics Expects $27.7M in Net Proceeds from Public Offering
July 26, 2012
Rosetta Genomics Expects $27.7M in Net Proceeds from Public Offering
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Rosetta Genomics' 2012 Revenues Nearly Double
March 25, 2013 / GenomeWeb Daily News
People in the News: Ron Kalfus, Guy Malchi, Steve Miller
August 23, 2012 / Gene Silencing News
Rosetta, Precision Therapeutics Reach Co-marketing Deal for miRview mets2 Assay
July 24, 2012 / GenomeWeb Daily News
Rosetta Genomics Terminates Deal with Avatao
July 17, 2012 / GenomeWeb Daily News
Rosetta Publishes Data on microRNA-Based Lung Cancer Assay
July 5, 2012 / Gene Silencing News